Page last updated: 2024-08-17

colchicine and Cytokine Release Syndrome

colchicine has been researched along with Cytokine Release Syndrome in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's9 (100.00)2.80

Authors

AuthorsStudies
Abdeen, S; Abu-Fanne, R; Bdeir, K; Cines, DB; Heyman, SN; Higazi, AA; Higazi, M; Maraga, E1
Aboshanab, KM; Ismail, NSM; Kamel, NA; Yahia, IS1
Al-Gareeb, AI; Al-Kuraishy, HM; Al-Niemi, MS; Hussien, NR1
Abbas, Y; Ali, R; Allergini, P; Ashraf, S; Asif, H; Farooq, U; Ghafoor, A; Gillani, SY; Haroon, MZ; Irshad, R; Khalil, AT; Khan, A; Khan, S; Livingstone, S; Malik, S; Masood, A; Mehmood, Z; Nigar, R; Pascual-Figal, DA; Riva, A; Togni, S; Ujjan, ID; Zeb, S1
Azad, KAK; Datta, PK; Faruq, I; Haque, M; Hasan, P; Islam, K; Mahmud, R; Mallik, U; Miah, T; Rahman, M; Rahman, MM; Ratul, RH; Sharif, M1
Dagna, L; Della-Torre, E; Della-Torre, F; Kusanovic, M; Ramirez, GA; Scotti, R; Tresoldi, M1
Mansouri, D; Mansouri, N; Marjani, M; Tabarsi, P; von Garnier, C1
Burrage, DR; Koushesh, S; Sofat, N1
Ferrara, F; Vitiello, A1

Reviews

4 review(s) available for colchicine and Cytokine Release Syndrome

ArticleYear
Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.
    Medicina (Kaunas, Lithuania), 2021, Dec-23, Volume: 58, Issue:1

    Topics: Colchicine; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Molecular Docking Simulation; SARS-CoV-2

2021
Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature.
    Immunological investigations, 2021, Volume: 50, Issue:8

    Topics: Administration, Oral; Adult; Colchicine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Gout; Humans; Male; SARS-CoV-2; Treatment Outcome

2021
Immunomodulatory Drugs in the Management of SARS-CoV-2.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Female; Humans; Hydroxychloroquine; Immunomodulation; Janus Kinase Inhibitors; Middle Aged; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Tumor Necrosis Factor-alpha

2020
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state.
    Respiratory medicine, 2021, Volume: 178

    Topics: Colchicine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; SARS-CoV-2; Tubulin Modulators

2021

Trials

3 trial(s) available for colchicine and Cytokine Release Syndrome

ArticleYear
Divergent impacts of tocilizumab and colchicine in COVID-19-associated coagulopathy: the role of alpha-defensins.
    British journal of haematology, 2022, Volume: 196, Issue:4

    Topics: Aged; alpha-Defensins; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Blood Coagulation; Colchicine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Female; Fibrin Fibrinogen Degradation Products; Humans; Interleukin-6; Male; Middle Aged; Neutrophils

2022
Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2022, Volume: 73, Issue:3

    Topics: Anti-Inflammatory Agents; Colchicine; COVID-19 Drug Treatment; Cytokine Release Syndrome; Hospitalization; Humans; SARS-CoV-2; Treatment Outcome

2022
Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial.
    PloS one, 2022, Volume: 17, Issue:11

    Topics: Bangladesh; Clinical Deterioration; Colchicine; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Respiratory Distress Syndrome; SARS-CoV-2; Treatment Outcome

2022

Other Studies

2 other study(ies) available for colchicine and Cytokine Release Syndrome

ArticleYear
Colchicine in the management of Covid-19: With or lieu of evidence.
    JPMA. The Journal of the Pakistan Medical Association, 2021, Volume: 71(Suppl 8), Issue:12

    Topics: Anti-Inflammatory Agents; Colchicine; COVID-19; Cytokine Release Syndrome; Cytokines; Humans; SARS-CoV-2

2021
Treating COVID-19 with colchicine in community healthcare setting.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 217

    Topics: Acetaminophen; Anti-Inflammatory Agents; Azithromycin; Betacoronavirus; Cohort Studies; Colchicine; Community Health Services; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Fever; Gene Expression; Humans; Immunity, Innate; Inflammasomes; Intensive Care Units; Interleukin-1; Interleukin-6; Italy; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Time Factors

2020